HAEMONETICS CORP/MASS (HAE) Forecast, Price Target & Analyst Ratings

NYSE:HAE • US4050241003

Current stock price

57.32 USD
-1.1 (-1.88%)
At close:
57.32 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HAEMONETICS CORP/MASS (HAE).

Forecast Snapshot

Consensus Price Target

Price Target
$89.25
+ 55.70% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q4 / 2026
EPS Estimate
$1.28
Revenue Estimate
340.41M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$89.25
Upside
+ 55.70%
From current price of $57.32 to mean target of $89.25, Based on 15 analyst forecasts
Low
$70.70
Median
$90.78
High
$113.40

Price Target Revisions

1 Month
-0.57%
3 Months
-4.58%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for HAE. The average price target is 89.25 USD. This implies a price increase of 55.7% is expected in the next year compared to the current price of 57.32.
The average price target has been revised downward by 4.58% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HAE Current Analyst RatingHAE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

HAE Historical Analyst RatingsHAE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
78.67%
HAE was analyzed by 15 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about HAE.
In the previous month the buy percentage consensus was at a similar level.
HAE was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-11CitigroupMaintains Neutral -> Neutral
2026-02-06Barrington ResearchMaintains Outperform -> Outperform
2026-02-06MizuhoMaintains Outperform -> Outperform
2026-02-06BTIGReiterate Buy -> Buy
2026-02-06CitigroupMaintains Neutral -> Neutral
2026-02-02Barrington ResearchMaintains Outperform -> Outperform
2026-01-12Barrington ResearchMaintains Outperform -> Outperform
2026-01-09BTIGReiterate Buy -> Buy
2025-12-17MizuhoMaintains Outperform -> Outperform
2025-12-15NeedhamDowngrade Buy -> Hold
2025-12-15BairdMaintains Outperform -> Outperform
2025-12-12JP MorganMaintains Neutral -> Neutral
2025-12-11CitigroupDowngrade Buy -> Neutral
2025-11-21BTIGReiterate Buy -> Buy
2025-11-07Barrington ResearchMaintains Outperform -> Outperform
2025-11-07NeedhamMaintains Buy -> Buy
2025-11-06BTIGMaintains Buy -> Buy
2025-10-21Barrington ResearchMaintains Outperform -> Outperform
2025-10-07CitigroupMaintains Buy -> Buy
2025-09-23Barrington ResearchMaintains Outperform -> Outperform
2025-08-11Raymond JamesDowngrade Strong Buy -> Outperform
2025-08-08Barrington ResearchMaintains Outperform -> Outperform
2025-08-08MizuhoMaintains Outperform -> Outperform
2025-08-08JP MorganDowngrade Overweight -> Neutral
2025-08-07NeedhamMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q4 / 2026
EPS Estimate
$1.28
Revenue Estimate
340.41M
Revenue Q2Q
2.97%
EPS Q2Q
3.58%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.10%
EPS (1 Month)
0.00%
EPS (3 Months)
-1.89%

Next Earnings Summary

HAE is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is 1.28 USD and the consensus revenue estimate is 340.41M USD.
The next earnings revenue estimate has been revised downward by 0.1% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
HAE revenue by date.HAE revenue by date.
1.169B
17.67%		1.309B
12.01%		1.361B
3.95%		1.338B
-1.68%		1.408B
5.23%		1.499B
6.46%
EBITDA
YoY % growth
HAE ebitda by date.HAE ebitda by date.
261.5M
31.87%		310.449M
18.72%		360.834M
16.23%		432.78M
19.94%		437.68M
1.13%		485.98M
11.04%
EBIT
YoY % growth
HAE ebit by date.HAE ebit by date.
168.2M
67.20%		213.234M
26.77%		245.248M
15.01%		348.17M
41.97%		375.49M
7.85%		410.82M
9.41%
Operating Margin
HAE operating margin by date.HAE operating margin by date.
14.39%16.29%18.02%26.02%26.67%27.41%
EPS
YoY % growth
HAE eps by date.HAE eps by date.
3.03
16.99%		3.98
31.35%		4.57
14.82%		5.00
9.31%		5.30
6.05%		5.90
11.32%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		1.28
3.58%		1.18
6.99%		1.35
5.91%		1.41
7.67%		1.43
11.14%		1.33
13.28%		1.56
16.01%		1.62
14.57%		1.55
8.60%
Revenue
Q2Q % growth		340.41M
2.97%		336.04M
4.56%		348.99M
6.62%		360.88M
6.46%		357.34M
4.97%		366.52M
9.07%		378.93M
8.58%		389.8M
8.01%		384.5M
7.60%
EBITDA
Q2Q % growth		105.44M
-39.52%		97.46M
4.02%		108.47M
-12.73%		113.2M
-26.47%		119.51M
13.34%		110.7M
13.59%		124.76M
15.02%		127.59M
12.71%		122.74M
2.70%
EBIT
Q2Q % growth		91.518M
55.77%		84.082M
29.48%		94.356M
40.25%		98.43M
41.50%		97.677M
6.73%		92.795M
10.36%		106.57M
12.94%		109.89M
11.64%		105.57M
8.08%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HAE Yearly Revenue VS EstimatesHAE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
HAE Yearly EPS VS EstimatesHAE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
8.87%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
2.97%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
14.01%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HAEMONETICS CORP/MASS / HAE Forecast FAQ

What is the price target for HAE stock?

15 analysts have analysed HAE and the average price target is 89.25 USD. This implies a price increase of 55.7% is expected in the next year compared to the current price of 57.32.

When does HAEMONETICS CORP/MASS (HAE) report earnings?

HAEMONETICS CORP/MASS (HAE) will report earnings on 2026-05-07, after the market close.

Can you provide the consensus estimates for HAEMONETICS CORP/MASS next earnings?

The consensus EPS estimate for the next earnings of HAEMONETICS CORP/MASS (HAE) is 1.28 USD and the consensus revenue estimate is 340.41M USD.

Can you provide the analyst count for HAEMONETICS CORP/MASS stock?

The number of analysts covering HAEMONETICS CORP/MASS (HAE) is 15.